About Bacillus Coagulans
Bacillus coagulans is a beneficial bacteria utilized as a probiotic. The bacteria’s ability to withstand harsh acidic environments has led to its adoption in probiotics, which specifically target the human digestive system. It is useful in alleviating constipation, stomach ailments, abdominal pain, irritable bowel syndrome, and flatulence. Due to the bacteria’s efficacious properties, it finds application in both human and animal nutrition. Other beneficial properties include improved immunity, anti-carcinogenic agent, and prevention of respiratory disorders. The interest in probiotic foods is increasing due to the growing consumer demand for safe and functional foods with high nutritional value and health-promoting properties and this is anticipating the growth of the bacillus coagulans market in the forecast period.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
The global bacillus coagulans market is highly competitive. Companies operating in this market focus more on R&D activities to develop new products. Novel applications are developed by companies to strengthen their presence. The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies.The Players having a strong hold in the market are Ganeden, Inc., UAS Laboratories, and Sabinsa. Analyst at AMA Research estimates that Asian Players will contribute the maximum growth to Global Bacillus Coagulans market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Ganeden, Inc. (United States), UAS Laboratories (United States), Sabinsa (United States), Mitsubishi-Chemical Foods Corporation (Japan), Syngen Biotech (Taiwan), Sanzyme (India), Mystical Biotech Pvt Ltd. (India), Aumgene Bioscience (India) and Unique Biotech (India) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Bacillus Coagulans market by Type (Pharmaceutical grade, Food Grade and Others), Application (Pharmaceuticals, Food Industry, Feed Industry and Others) and Region.
On the basis of geography, the market of Bacillus Coagulans has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hypermarkets/Supermarkets will boost the Bacillus Coagulans market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growing Demand for Bacillus Coagulans from Developing Economies
Market Growth Drivers:
Increasing Applications of Bacillus Coagulans in Herbal Medicines and Food and Beverages Industry, Rising number of Digestive Disorders like Abdominal Pain, Stomach Ailments, Flatulence, Irritable Bowel Syndrome, and Constipation and Growing Geriatric Population Globally
Challenges:
Low Awareness among Consumers for The Health Benefits Offered By Bacillus Coagulans
Restraints:
Bacillus Coagulans carelessness in dosage can result in intestinal gas and bloating
Opportunities:
Increasing Prevalence of Digestive Disorders
Market Leaders and their expansionary development strategies
After all closing requirements were met, Chr. Hansen Holding A/S ("Chr. Hansen") successfully completed the acquisition of UAS Laboratories LLC ("UAS Labs")
Two of Mitsubishi Chemical Corporation's subsidiaries, Wuxi Lingyang Green Agricultural System & Technology Co., Ltd. and Mitsubishi Chemical Agri Dream Co., Ltd., entered into strategic cooperation with Shenyang Qiushi Agricultural Science and Technology Development Co., Ltd.
Key Target Audience
Bacillus Coagulans Manufacturers, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors and Other
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.